Omico's Bruce Goodwin on PrOSPeCT trials as a platform for change

Omico's Bruce Goodwin says the launch of Australia's largest cancer genomics initiative, known as PrOSPeCT, signals the next step for a project that is already benefiting patients but also has the potential to create a new accessible platform for clinical trials and a framework for policy reform. …